$EPZM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Epizyme, Inc.. Get notifications about new insider transactions in Epizyme, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 30,613 | 28.9 K to 30.6 K (+5.81 %) |
| Oct 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 777 | 0 | 21,766 | |
| Oct 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 47,093 | |
| Oct 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 9.72 | 1,013 | 9,848 | 28,931 | 29.9 K to 28.9 K (-3.38 %) |
| Oct 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 777 | 0 | 29,944 | 29.2 K to 29.9 K (+2.66 %) |
| Oct 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 29,167 | 27.5 K to 29.2 K (+6.12 %) |
| Sep 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 777 | 0 | 22,543 | |
| Sep 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 48,775 | |
| Sep 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 7.55 | 1,013 | 7,651 | 27,485 | 28.5 K to 27.5 K (-3.55 %) |
| Sep 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 777 | 0 | 28,498 | 27.7 K to 28.5 K (+2.80 %) |
| Sep 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 27,721 | 26 K to 27.7 K (+6.46 %) |
| Sep 01 2016 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Grant | A | 6.21 | 1,362 | 8,463 | 5,720 | 4.4 K to 5.7 K (+31.25 %) |
| Sep 01 2016 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Grant | A | 6.21 | 1,362 | 8,463 | 1,362 | 0 to 1.4 K |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 778 | 0 | 23,320 | |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 778 | 0 | 23,320 | |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 50,457 | |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 50,457 | |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 9.05 | 1,013 | 9,166 | 26,039 | 27.1 K to 26 K (-3.74 %) |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 9.05 | 1,013 | 9,166 | 26,039 | 27.1 K to 26 K (-3.74 %) |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 778 | 0 | 27,052 | 26.3 K to 27.1 K (+2.96 %) |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 26,274 | 24.6 K to 26.3 K (+6.84 %) |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 778 | 0 | 27,052 | 26.3 K to 27.1 K (+2.96 %) |
| Aug 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 26,274 | 24.6 K to 26.3 K (+6.84 %) |
| Aug 03 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 4,000 | 8,760 | 2,000 | |
| Aug 03 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 10.37 | 4,000 | 41,492 | 31,538 | 35.5 K to 31.5 K (-11.26 %) |
| Aug 03 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 4,000 | 8,760 | 35,538 | 31.5 K to 35.5 K (+12.68 %) |
| Jul 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 777 | 0 | 24,098 | |
| Jul 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 52,139 | |
| Jul 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 10.36 | 1,013 | 10,494 | 24,592 | 25.6 K to 24.6 K (-3.96 %) |
| Jul 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 777 | 0 | 25,605 | 24.8 K to 25.6 K (+3.13 %) |
| Jul 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 24,828 | 23.1 K to 24.8 K (+7.27 %) |
| Jul 07 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 4,000 | 8,760 | 6,000 | |
| Jul 07 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 10.03 | 4,000 | 40,128 | 0 | 4 K to 0 (-100.00 %) |
| Jul 07 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 4,000 | 8,760 | 4,000 | 0 to 4 K |
| Jul 06 2016 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 10.33 | 6,000 | 61,980 | 6,000 | 0 to 6 K |
| Jul 06 2016 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Grant | A | 10.33 | 3,200 | 33,056 | 3,200 | 0 to 3.2 K |
| Jun 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 777 | 0 | 24,875 | |
| Jun 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 53,821 | |
| Jun 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 12.49 | 1,013 | 12,656 | 23,146 | 24.2 K to 23.1 K (-4.19 %) |
| Jun 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 777 | 0 | 24,159 | 23.4 K to 24.2 K (+3.32 %) |
| Jun 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 23,382 | 21.7 K to 23.4 K (+7.75 %) |
| Jun 02 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 3.54 | 31,538 | 111,645 | 4,098 | |
| Jun 02 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 3.54 | 31,538 | 111,645 | 31,538 | 0 to 31.5 K |
| May 23 2016 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
| May 23 2016 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
| May 23 2016 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
| May 23 2016 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
| May 23 2016 | EPZM | Epizyme, Inc. | POPS RICHARD F | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
| May 23 2016 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
| May 17 2016 | EPZM | Epizyme, Inc. | Ros Matthew | Chief Operating Off ... | Option Exercise | A | 9.58 | 173,438 | 1,661,536 | 173,438 | |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 778 | 0 | 25,652 | |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 55,503 | |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 10.13 | 320 | 3,241 | 21,700 | 22 K to 21.7 K (-1.45 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 10.13 | 76 | 770 | 22,020 | 22.1 K to 22 K (-0.34 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 9.57 | 617 | 5,904 | 22,096 | 22.7 K to 22.1 K (-2.72 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 778 | 0 | 22,713 | 21.9 K to 22.7 K (+3.55 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 21,935 | 20.3 K to 21.9 K (+8.30 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 778 | 0 | 25,652 | |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 55,503 | |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 10.13 | 320 | 3,241 | 21,700 | 22 K to 21.7 K (-1.45 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 10.13 | 76 | 770 | 22,020 | 22.1 K to 22 K (-0.34 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 9.57 | 617 | 5,904 | 22,096 | 22.7 K to 22.1 K (-2.72 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 778 | 0 | 22,713 | 21.9 K to 22.7 K (+3.55 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 21,935 | 20.3 K to 21.9 K (+8.30 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 777 | 0 | 26,430 | |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 57,185 | |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 12.14 | 173 | 2,100 | 20,253 | 20.4 K to 20.3 K (-0.85 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 12.48 | 840 | 10,483 | 20,426 | 21.3 K to 20.4 K (-3.95 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 777 | 0 | 21,266 | 20.5 K to 21.3 K (+3.79 %) |
| May 12 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 20,489 | 18.8 K to 20.5 K (+8.94 %) |
| Apr 26 2016 | EPZM | Epizyme, Inc. | Graf Susan E | Chief Business Offi ... | Option Exercise | A | 12.12 | 178,642 | 2,165,141 | 178,642 | |
| Mar 11 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 777 | 0 | 27,207 | |
| Mar 11 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 58,867 | |
| Mar 11 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 8.70 | 100 | 870 | 18,807 | 18.9 K to 18.8 K (-0.53 %) |
| Mar 11 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 9.40 | 906 | 8,516 | 18,907 | 19.8 K to 18.9 K (-4.57 %) |
| Mar 11 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 777 | 0 | 19,813 | 19 K to 19.8 K (+4.08 %) |
| Mar 11 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 19,036 | 17.4 K to 19 K (+9.69 %) |
| Mar 02 2016 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 7.47 | 636 | 4,752 | 5,358 | 4.7 K to 5.4 K (+13.47 %) |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 9,329 | 0 | 27,984 | |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 20,183 | 0 | 60,549 | |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | A | 0.00 | 80,732 | 0 | 80,732 | |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | A | 8.98 | 76,400 | 686,072 | 76,400 | |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 9.54 | 12,158 | 115,987 | 17,354 | 29.5 K to 17.4 K (-41.20 %) |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 9,329 | 0 | 29,512 | 20.2 K to 29.5 K (+46.22 %) |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 20,183 | 0 | 20,183 | 0 to 20.2 K |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | A | 8.98 | 122,200 | 1,097,356 | 122,200 | |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Option Exercise | A | 8.98 | 229,200 | 2,058,216 | 229,200 | |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | A | 8.98 | 412,500 | 3,704,250 | 412,500 | |
| Apr 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 777 | 0 | 26,430 | |
| Apr 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | M | 0.00 | 1,682 | 0 | 57,185 | |
| Apr 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 12.14 | 173 | 2,100 | 20,253 | 20.4 K to 20.3 K (-0.85 %) |
| Apr 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Sell | S | 12.48 | 840 | 10,483 | 20,426 | 21.3 K to 20.4 K (-3.95 %) |
| Apr 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 777 | 0 | 21,266 | 20.5 K to 21.3 K (+3.79 %) |
| Apr 13 2016 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Buy | M | 0.00 | 1,682 | 0 | 20,489 | 18.8 K to 20.5 K (+8.94 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Buy | P | 9.00 | 10,389 | 93,501 | 3,380,951 | 3.4 M to 3.4 M (+0.31 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Buy | P | 9.00 | 545,166 | 4,906,494 | 3,370,562 | 2.8 M to 3.4 M (+19.30 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 9.00 | 10,389 | 93,501 | 3,380,951 | 3.4 M to 3.4 M (+0.31 %) |
| Jan 12 2016 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 9.00 | 545,166 | 4,906,494 | 3,370,562 | 2.8 M to 3.4 M (+19.30 %) |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 3,893 | 8,526 | 10,000 | |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 3.54 | 292 | 1,034 | 28,806 | |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 15.58 | 3,893 | 60,635 | 0 | 3.9 K to 0 (-100.00 %) |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 3,893 | 8,526 | 3,893 | 0 to 3.9 K |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 15.58 | 292 | 4,548 | 0 | 292 to 0 (-100.00 %) |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 3.54 | 292 | 1,034 | 292 | 0 to 292 |
| Dec 31 2015 | EPZM | Epizyme, Inc. | Gould Robert J | Director | Option Exercise | M | 0.51 | 11,805 | 6,021 | 355,115 | |
| Dec 31 2015 | EPZM | Epizyme, Inc. | Gould Robert J | Director | Option Exercise | M | 0.51 | 20,303 | 10,355 | 366,920 | |
| Dec 31 2015 | EPZM | Epizyme, Inc. | Gould Robert J | Director | Sell | S | 18.02 | 11,805 | 212,713 | 0 | 11.8 K to 0 (-100.00 %) |
| Dec 31 2015 | EPZM | Epizyme, Inc. | Gould Robert J | Director | Buy | M | 0.51 | 11,805 | 6,021 | 11,805 | 0 to 11.8 K |
| Dec 31 2015 | EPZM | Epizyme, Inc. | Gould Robert J | Director | Sell | S | 18.01 | 20,303 | 365,618 | 0 | 20.3 K to 0 (-100.00 %) |
| Dec 31 2015 | EPZM | Epizyme, Inc. | Gould Robert J | Director | Buy | M | 0.51 | 20,303 | 10,355 | 20,303 | 0 to 20.3 K |
| Dec 10 2015 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 14.69 | 1,000 | 14,690 | 4,722 | 3.7 K to 4.7 K (+26.87 %) |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 2,503 | 5,482 | 13,893 | |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 1,682 | 1,009 | 0 | |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 13.82 | 2,503 | 34,595 | 0 | 2.5 K to 0 (-100.00 %) |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 2,503 | 5,482 | 2,503 | 0 to 2.5 K |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 13.82 | 1,682 | 23,248 | 0 | 1.7 K to 0 (-100.00 %) |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 1,682 | 1,009 | 1,682 | 0 to 1.7 K |
| Nov 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 4,185 | 2,511 | 1,682 | |
| Nov 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 16.26 | 4,185 | 68,059 | 0 | 4.2 K to 0 (-100.00 %) |
| Nov 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 4,185 | 2,511 | 4,185 | 0 to 4.2 K |
| Oct 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 4,185 | 2,511 | 5,867 | |
| Oct 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 14.43 | 4,185 | 60,380 | 0 | 4.2 K to 0 (-100.00 %) |
| Oct 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 4,185 | 2,511 | 4,185 | 0 to 4.2 K |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 4,185 | 2,511 | 10,052 | |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 19.58 | 4,185 | 81,921 | 0 | 4.2 K to 0 (-100.00 %) |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 4,185 | 2,511 | 4,185 | 0 to 4.2 K |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Option Exercise | M | 0.51 | 60,000 | 30,600 | 387,223 | |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 19.25 | 700 | 13,475 | 0 | 700 to 0 (-100.00 %) |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 19.87 | 59,300 | 1,178,267 | 700 | 60 K to 700 (-98.83 %) |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Buy | M | 0.51 | 60,000 | 30,600 | 60,000 | 0 to 60 K |
| Sep 02 2015 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 17.00 | 522 | 8,874 | 3,522 | 3 K to 3.5 K (+17.40 %) |
| Aug 24 2015 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 16.51 | 2,000 | 33,020 | 3,000 | 1,000 to 3 K (+200.00 %) |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 8,370 | 5,022 | 14,237 | |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 22.19 | 8,370 | 185,727 | 0 | 8.4 K to 0 (-100.00 %) |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 8,370 | 5,022 | 8,370 | 0 to 8.4 K |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Option Exercise | M | 0.51 | 60,000 | 30,600 | 447,223 | |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 22.40 | 4,200 | 94,074 | 0 | 4.2 K to 0 (-100.00 %) |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 21.94 | 55,800 | 1,224,280 | 4,200 | 60 K to 4.2 K (-93.00 %) |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Buy | M | 0.51 | 60,000 | 30,600 | 60,000 | 0 to 60 K |
| Jul 10 2015 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 |